#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease Alpha-1 antitrypsin deficiency Follicular lymphoma stage III Congenital generalised lipodystrophy Wiskott-Aldrich syndrome Acute hepatic failure Neurofibroma Thermal burn Oesophageal carcinoma Necrotising myositis Polyneuropathy Endocrine ophthalmopathy Metastases to peritoneum Squamous cell carcinoma of the vulva Autoimmune myositis More trials…

    Learn about Rare Diseases

    Antisynthetase syndrome – Life with Disease Hereditary ataxia – Diagnostics Ewing’s sarcoma – Diagnostics Anaplastic thyroid cancer – Treatment Haemophilia A without inhibitors – Diagnostics Synovial sarcoma recurrent – Basic Information Chondrosarcoma metastatic Stevens-Johnson syndrome – Diagnostics Factor VIII deficiency – Treatment Haemophilia A with anti factor VIII – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Voriconazole Azd5863 Arachis Hypogaea Extract Fosfomycin Trometamol Volrustomig ARI0008 Viltolarsen Jab-21822 Clarithromycin Lifileucel Mps-215 Rbl035.2 Pevonedistat Rozanolixizumab Tyra-300-B01 S095035 Bemcentinib Tinengotinib LY3848575 Alectinib Hydrochloride More therapies…

    Learn about Your Condition

    Aphthous ulcer Endotracheal intubation Metastases to meninges Stress Urethral valves Nephropathy Neoplasm malignant Eczema Acute myocardial infarction Delirium Angina pectoris Astrocytoma malignant Acute on chronic liver failure Pulmonary alveolar haemorrhage Cardiac valve disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • Study on the Effects of AZD5004 and Semaglutide for Adults with Type 2 Diabetes

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Azd5004
    • Semaglutide
    Germany Hungary Poland Slovakia Spain

  • Study on Liraglutide for Weight Management in Children Aged 6 to 12 with Obesity

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Liraglutide
    Belgium Portugal

  • Study on the Safety of A24110He for Patients with Type 2 Diabetes and High Triglycerides

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Hypertriglyceridaemia
    Investigated Drugs:
    • A24110He
    • Human Albumin Solution
    • Insulin Human (Rdna)
    Sweden

  • Study on the Effects of Pariglasgene Brecaparvovec for Adults with Glycogen Storage Disease Type Ia

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Glycogen storage disease type I
    Investigated Drugs:
    • Pariglasgene Brecaparvovec
    The Netherlands Spain

  • Study on the Effects of Semaglutide on Diabetic Eye Disease in People with Type 2 Diabetes

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Semaglutide
    Bulgaria Czechia Germany Greece Latvia Poland +4

  • Study Comparing Orforglipron and Dapagliflozin for Adults with Type 2 Diabetes and Poor Blood Sugar Control on Metformin

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Metformin
    • Dapagliflozin
    Germany Poland
Previous Page
1 … 44 45 46 47 48 … 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!